JUST IN: FDA advisory panel votes to recommend a second dose of Johnson & Johnson's Covid-19 vaccine for emergency use authorization.
The Johnson & Johnson booster would be available for all of the nearly 15 million people ages 18 and up who received that vaccine. That’s a departure from the recommendations for Pfizer-BioNTech and Moderna boosters, which are limited to those aged 65 and up, aged 18 to 64 with either underlying health conditions, or whose job that puts them at high risk of exposure to Covid-19.
In fact, many committee members argued that Johnson & Johnson’s vaccination regime should simply be considered a two-dose vaccine, just like the Pfizer and Moderna vaccines, rather than a single shot plus a booster. That drew particularly pointed criticism from the FDA. Dr. Peter Marks, the director of the agency’s Center for Biologics Evaluation and Research, went as far as to suggest that the company was not presenting the full picture, particularly in terms of the real-world effectiveness of a single dose.72 percent effective against moderate to severe illness
Marks, however, said that “there are data that suggests the effectiveness of this vaccine is actually less robust than the company’s presentation here.”Dr.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 Live Updates: FDA to vote on Johnson & Johnson vaccine booster shot after Moderna approvedAn FDA expert panel will vote on whether to support or oppose a booster shot for the Johnson & Johnson COVID-19 vaccine. Follow Newsweek's liveblog for all the latest.
Baca lebih lajut »
Independent FDA panel votes to authorize booster shots for Johnson & Johnson vaccineBREAKING: An independent FDA advisory panel has voted to authorize Johnson & Johnson Covid-19 vaccine boosters to all J&J recipients 18 and older.
Baca lebih lajut »
FDA advisory group recommends Moderna booster for emergency useJUST IN: FDA advisory panel votes to recommend Moderna booster shots for emergency use authorization for certain at-risk groups.
Baca lebih lajut »
FDA advisory group recommends Moderna booster for emergency useThe decision will now go to the Food and Drug Administration, which is expected to make a final ruling in the coming days.
Baca lebih lajut »
FDA to take up Moderna, J&J Covid-19 booster questions this weekVaccine advisers to the FDA meet Thursday and Friday of this week to tackle the next round of questions about booster vaccines for Covid-19 — and they might be seeing the first trickle of data on mix-and-match boosters.
Baca lebih lajut »
FDA spells out lower sodium goals for food industryNEW YORK (AP) — Food companies are coming under renewed pressure to use less salt after U.S. regulators spelled out long-awaited guidelines aimed at reducing sodium levels in dozens of foods including condiments, cereals, french fries and potato chips.
Baca lebih lajut »